Cargando…

Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma

INTRODUCTION: Chromophobe renal cell carcinoma presents in early pathological stages with a lower risk of metastasis. However, aggressive features and metastasis can occur. A rare case of rapidly progressive disease with histological changes is presented. CASE PRESENTATION: A 56‐year‐old woman had a...

Descripción completa

Detalles Bibliográficos
Autores principales: Honda‐Takinami, Ruriko, Ishibashi, Kei, Onagi, Akifumi, Tanji, Ryo, Matsuoka, Kanako, Hoshi, Seiji, Koguchi, Tomoyuki, Hata, Junya, Yabe, Michihiro, Sato, Yuichi, Akaihata, Hidenori, Kataoka, Masao, Ogawa, Soichiro, Haga, Nobuhiro, Kojima, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292175/
https://www.ncbi.nlm.nih.gov/pubmed/32743465
http://dx.doi.org/10.1002/iju5.12135
_version_ 1783546055050133504
author Honda‐Takinami, Ruriko
Ishibashi, Kei
Onagi, Akifumi
Tanji, Ryo
Matsuoka, Kanako
Hoshi, Seiji
Koguchi, Tomoyuki
Hata, Junya
Yabe, Michihiro
Sato, Yuichi
Akaihata, Hidenori
Kataoka, Masao
Ogawa, Soichiro
Haga, Nobuhiro
Kojima, Yoshiyuki
author_facet Honda‐Takinami, Ruriko
Ishibashi, Kei
Onagi, Akifumi
Tanji, Ryo
Matsuoka, Kanako
Hoshi, Seiji
Koguchi, Tomoyuki
Hata, Junya
Yabe, Michihiro
Sato, Yuichi
Akaihata, Hidenori
Kataoka, Masao
Ogawa, Soichiro
Haga, Nobuhiro
Kojima, Yoshiyuki
author_sort Honda‐Takinami, Ruriko
collection PubMed
description INTRODUCTION: Chromophobe renal cell carcinoma presents in early pathological stages with a lower risk of metastasis. However, aggressive features and metastasis can occur. A rare case of rapidly progressive disease with histological changes is presented. CASE PRESENTATION: A 56‐year‐old woman had a right renal tumor with multiple lymph node metastases, and the pathological diagnosis of the biopsy specimens from the primary tumor was chromophobe renal cell carcinoma. After sunitinib treatment, the metastatic lymph node had decreased in size and the numbers of circulating tumor cells were decreased, consequently, cytoreductive nephrectomy was performed. However, rapid progression of lymph node metastases was observed. Histopathological examination showed that the renal tumor was diagnosed as spindle cell renal carcinoma. CONCLUSION: It appears that the primary tumor underwent epithelial‐mesenchymal transition; further tissue specimen collection and analysis might be needed.
format Online
Article
Text
id pubmed-7292175
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-72921752020-07-30 Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma Honda‐Takinami, Ruriko Ishibashi, Kei Onagi, Akifumi Tanji, Ryo Matsuoka, Kanako Hoshi, Seiji Koguchi, Tomoyuki Hata, Junya Yabe, Michihiro Sato, Yuichi Akaihata, Hidenori Kataoka, Masao Ogawa, Soichiro Haga, Nobuhiro Kojima, Yoshiyuki IJU Case Rep Case Reports INTRODUCTION: Chromophobe renal cell carcinoma presents in early pathological stages with a lower risk of metastasis. However, aggressive features and metastasis can occur. A rare case of rapidly progressive disease with histological changes is presented. CASE PRESENTATION: A 56‐year‐old woman had a right renal tumor with multiple lymph node metastases, and the pathological diagnosis of the biopsy specimens from the primary tumor was chromophobe renal cell carcinoma. After sunitinib treatment, the metastatic lymph node had decreased in size and the numbers of circulating tumor cells were decreased, consequently, cytoreductive nephrectomy was performed. However, rapid progression of lymph node metastases was observed. Histopathological examination showed that the renal tumor was diagnosed as spindle cell renal carcinoma. CONCLUSION: It appears that the primary tumor underwent epithelial‐mesenchymal transition; further tissue specimen collection and analysis might be needed. John Wiley and Sons Inc. 2020-01-10 /pmc/articles/PMC7292175/ /pubmed/32743465 http://dx.doi.org/10.1002/iju5.12135 Text en © 2020 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Honda‐Takinami, Ruriko
Ishibashi, Kei
Onagi, Akifumi
Tanji, Ryo
Matsuoka, Kanako
Hoshi, Seiji
Koguchi, Tomoyuki
Hata, Junya
Yabe, Michihiro
Sato, Yuichi
Akaihata, Hidenori
Kataoka, Masao
Ogawa, Soichiro
Haga, Nobuhiro
Kojima, Yoshiyuki
Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
title Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
title_full Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
title_fullStr Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
title_full_unstemmed Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
title_short Spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
title_sort spindle cell renal cell carcinoma diagnosed after sunitinib treatment for chromophobe renal cell carcinoma
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292175/
https://www.ncbi.nlm.nih.gov/pubmed/32743465
http://dx.doi.org/10.1002/iju5.12135
work_keys_str_mv AT hondatakinamiruriko spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT ishibashikei spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT onagiakifumi spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT tanjiryo spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT matsuokakanako spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT hoshiseiji spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT koguchitomoyuki spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT hatajunya spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT yabemichihiro spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT satoyuichi spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT akaihatahidenori spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT kataokamasao spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT ogawasoichiro spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT haganobuhiro spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma
AT kojimayoshiyuki spindlecellrenalcellcarcinomadiagnosedaftersunitinibtreatmentforchromophoberenalcellcarcinoma